Furthermore, studies using large-scale sequencing of cDNA libraries derived from brain plaques dissected from patients with MS identified an abundance of transcripts for osteopontin (OPN), a regulator of Th1 cells, and would be a promising therapeutic target to decelerate the development of progressive MS (Chabas et al., 2001). The gene discussed is SPP1; the disease is myeloid sarcoma.